331 related articles for article (PubMed ID: 29481553)
1. Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation.
Beare PA; Jeffrey BM; Long CM; Martens CM; Heinzen RA
PLoS Pathog; 2018 Mar; 14(3):e1006922. PubMed ID: 29481553
[TBL] [Abstract][Full Text] [Related]
2. Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons.
Beare PA; Samuel JE; Howe D; Virtaneva K; Porcella SF; Heinzen RA
J Bacteriol; 2006 Apr; 188(7):2309-24. PubMed ID: 16547017
[TBL] [Abstract][Full Text] [Related]
3. A simple method for enrichment of phase I Coxiella burnetii.
Anderson MW; Binette P; Richards C; Beare PA; Heinzen RA; Long CM
J Microbiol Methods; 2023 Aug; 211():106787. PubMed ID: 37453478
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide of Coxiella burnetii.
Narasaki CT; Toman R
Adv Exp Med Biol; 2012; 984():65-90. PubMed ID: 22711627
[TBL] [Abstract][Full Text] [Related]
5. The SCID Mouse Model for Identifying Virulence Determinants in
van Schaik EJ; Case ED; Martinez E; Bonazzi M; Samuel JE
Front Cell Infect Microbiol; 2017; 7():25. PubMed ID: 28217558
[No Abstract] [Full Text] [Related]
6. Comparative virulence of diverse Coxiella burnetii strains.
Long CM; Beare PA; Cockrell DC; Larson CL; Heinzen RA
Virulence; 2019 Dec; 10(1):133-150. PubMed ID: 30782062
[TBL] [Abstract][Full Text] [Related]
7. Proteomic comparison of virulent phase I and avirulent phase II of Coxiella burnetii, the causative agent of Q fever.
Skultety L; Hajduch M; Flores-Ramirez G; Miernyk JA; Ciampor F; Toman R; Sekeyova Z
J Proteomics; 2011 Sep; 74(10):1974-84. PubMed ID: 21616182
[TBL] [Abstract][Full Text] [Related]
8. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.
Shannon JG; Howe D; Heinzen RA
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8722-7. PubMed ID: 15939879
[TBL] [Abstract][Full Text] [Related]
9. Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells.
Kersh GJ; Oliver LD; Self JS; Fitzpatrick KA; Massung RF
Vector Borne Zoonotic Dis; 2011 Nov; 11(11):1433-8. PubMed ID: 21867419
[TBL] [Abstract][Full Text] [Related]
10. Cell-free propagation of Coxiella burnetii does not affect its relative virulence.
Kuley R; Smith HE; Frangoulidis D; Smits MA; Jan Roest HI; Bossers A
PLoS One; 2015; 10(3):e0121661. PubMed ID: 25793981
[TBL] [Abstract][Full Text] [Related]
11. EirA Is a Novel Protein Essential for Intracellular Replication of Coxiella burnetii.
Kuba M; Neha N; Newton P; Lee YW; Bennett-Wood V; Hachani A; De Souza DP; Nijagal B; Dayalan S; Tull D; McConville MJ; Sansom FM; Newton HJ
Infect Immun; 2020 May; 88(6):. PubMed ID: 32205404
[TBL] [Abstract][Full Text] [Related]
12. The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.
Islam A; Lockhart M; Stenos J; Graves S
Am J Trop Med Hyg; 2013 Oct; 89(4):800-3. PubMed ID: 23958905
[TBL] [Abstract][Full Text] [Related]
13. Coxiella burnetii Lipopolysaccharide: What Do We Know?
Abnave P; Muracciole X; Ghigo E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
[TBL] [Abstract][Full Text] [Related]
14. The hypervirulent Coxiella burnetii Guiana strain compared in silico, in vitro and in vivo to the Nine Mile and the German strain.
Melenotte C; Caputo A; Bechah Y; Lepidi H; Terras J; Kowalczewska M; Di Pinto F; Nappez C; Raoult D; Brégeon F
Clin Microbiol Infect; 2019 Sep; 25(9):1155.e1-1155.e8. PubMed ID: 30625413
[TBL] [Abstract][Full Text] [Related]
15. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice.
Andoh M; Zhang G; Russell-Lodrigue KE; Shive HR; Weeks BR; Samuel JE
Infect Immun; 2007 Jul; 75(7):3245-55. PubMed ID: 17438029
[TBL] [Abstract][Full Text] [Related]
16. The contribution of genomics to the study of Q fever.
D'Amato F; Eldin C; Raoult D
Future Microbiol; 2016; 11(2):253-72. PubMed ID: 26854360
[TBL] [Abstract][Full Text] [Related]
17. Coxiella burnetii lipopolysaccharide blocks p38α-MAPK activation through the disruption of TLR-2 and TLR-4 association.
Conti F; Boucherit N; Baldassarre V; Trouplin V; Toman R; Mottola G; Mege JL; Ghigo E
Front Cell Infect Microbiol; 2014; 4():182. PubMed ID: 25610812
[TBL] [Abstract][Full Text] [Related]
18. [First Isolation of Coxiella burnetii in Turkey from a Patient with Endocarditis; Antigen Production and Phase Change Study].
Çelebi B; Baş B; Agüloğlu Bali E; Şimşek Yavuz S
Mikrobiyol Bul; 2019 Jul; 53(3):274-284. PubMed ID: 31414629
[TBL] [Abstract][Full Text] [Related]
19. From cell culture to cynomolgus macaque: infection models show lineage-specific virulence potential of
Metters G; Norville IH; Titball RW; Hemsley CM
J Med Microbiol; 2019 Oct; 68(10):1419-1430. PubMed ID: 31424378
[No Abstract] [Full Text] [Related]
20. History and prospects of Coxiella burnetii research.
Hechemy KE
Adv Exp Med Biol; 2012; 984():1-11. PubMed ID: 22711624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
